Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9EAR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,263
Award facts
- Contract value 100% obligated
- $43,262.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $43,262.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of DESCOVY 200-25 mg tablets (30-count units), with a completion date of February 2, 2026. This is a non-set-aside, competitively awarded contract with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (formerly doing business as AmerisourceBergen), a major pharmaceutical distributor and critical federal healthcare vendor.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide. The DLA awards such contracts to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with strategic plans underway to establish next-generation Pharmaceutical Prime Vendor Global Program contracts across multiple regions.
Quick answers
Who was awarded contract SPE2DR26F9EAR?
SPE2DR26F9EAR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F9EAR worth?
The government has obligated $43,263 on SPE2DR26F9EAR.
Is contract SPE2DR26F9EAR an order under another contract?
Yes. SPE2DR26F9EAR is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9EAR competed?
The extent of competition for SPE2DR26F9EAR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award